Development of a highly sensitive genus-specific qRT-PCR assay

Click here to load reader

  • date post

    21-Jan-2017
  • Category

    Documents

  • view

    219
  • download

    0

Embed Size (px)

Transcript of Development of a highly sensitive genus-specific qRT-PCR assay

  • Development of a highly sensitive genus-specific qRT-PCR assay for detection and 1

    quantitation of Plasmodium by amplifying RNA and DNA of the 18S rRNA genes 2

    3

    Edwin Kamau1*

    , LaDonna S. Tolbert2, Luke Kortepeter

    1, Michael Pratt

    1, Nancy Nyakoe

    3, 4

    Linda Muringo3, Bernard Ogutu

    3, John N. Waitumbi

    3 and Christian F. Ockenhouse

    1. 5

    6

    1Division of Malaria Vaccine Development, United States Military Malaria Vaccine Program, 7

    Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America. 8

    2Division of Entomology, Molecular Diagnostics, Walter Reed Army Institute of Research, 9

    Silver Spring, Maryland, United States of America. 10

    3Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya 11

    12

    Running title: Total Nucleic Acids PCR Assay for Malaria Diagnosis 13

    Key words: Plasmodium, Malaria Diagnosis, real-time PCR, Microscopy, Malaria Elimination 14

    Abbreviations: Real-time PCR (qPCR), quantitative reverse transcriptase real-time PCR (qRT-15

    PCR), Limit of Detection (LOD), nucleic acids (NA), Malaria Research and Reference Reagent 16

    Resource Center (MR4), American Type Culture Collection (ATCC), reverse transcriptase (RT) 17

    *Corresponding author 18

    Division of Malaria Vaccine Development, Center for Molecular Diagnostics and Genomic 19

    Studies, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, 20

    Maryland, United States of America. 21

    22

    Telephone number: (301) 319 7572 23

    E-mail: Edwin.kamau@us.army.mil 24

    Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.J. Clin. Microbiol. doi:10.1128/JCM.00276-11 JCM Accepts, published online ahead of print on 8 June 2011

    on March 25, 2018 by guest

    http://jcm.asm

    .org/D

    ownloaded from

    http://jcm.asm.org/

  • Abstract 25

    26

    A highly sensitive genus-specific quantitative reverse transcriptase real-time PCR (qRT-PCR) 27

    assay for detection of Plasmodium has been developed. The assay amplifies total nucleic acids 28

    (RNA and DNA) of the 18S rRNA genes with a limit of detection of 0.002 parasites/L using 29

    cultured synchronized ring stage 3D7 parasites. Parasite densities as low as 0.000362 30

    parasites/L were detected when analyzing clinical samples. Analysis of clinical samples 31

    showed that detection of 18S rRNA genes from total nucleic acids increased the analytical 32

    sensitivity of the assay by more than a log-fold compared to DNA only. When clinical samples 33

    with no parasites present by microscopy were analyzed by qRT-PCR, 90% (117 of 130) were 34

    positive for presence of Plasmodium nucleic acids. Quantification of clinical samples by qRT-35

    PCR using total nucleic acid versus DNA was compared to microscopy. There was a 36

    significantly greater correlation of parasite density to microscopy when DNA alone was used 37

    compared to total nucleic acid. We conclude that analysis of total nucleic acids by qRT-PCR is a 38

    suitable assay in detection of low parasite levels in patients with early-stage malaria and/or 39

    submicroscopic infections and could greatly benefit malaria diagnosis, intervention trials, 40

    malaria control and elimination efforts. 41

    42

    43

    44

    45

    46

    47

    on March 25, 2018 by guest

    http://jcm.asm

    .org/D

    ownloaded from

    http://jcm.asm.org/

  • Introduction 48

    49

    Malaria remains one of the most devastating infectious diseases in the world. After many years 50

    of neglect, various philanthropies such as Roll Back Malaria (http://www.rbm.who.int) and 51

    Gates Foundation have now committed to its eventual eradication (7). The success of these new 52

    initiatives hinges in part with the use of effective diagnostic and surveillance methods (11). 53

    However, despite the revolutionary gains from molecular approaches in diagnosis of malaria, 54

    microscopy remains the gold standard for malaria diagnosis, clinical trials efficacy evaluation 55

    and epidemiological surveys not withstanding it shortcomings (15, 16). 56

    In expert hands, microscopy has a detection limit of 10 to 50 parasites/L (9, 12), but the 57

    average microscopist has a detection limit of about 100 parasites/L, thereby limiting the use of 58

    microscopy in cases of low parasite burden (2). Studies have shown that even at submicroscopic 59

    infections, mosquitoes do get infected and can potentially transmit malaria (13, 19). Therefore, 60

    as we move to the era of malaria control and elimination, highly sensitive methods with high 61

    throughput capabilities will be critical in parasite detection and surveillance. Such methods will 62

    be important in quantifying the extent of submicroscopic infections and giving a better insight 63

    into the dynamics of malaria transmission. 64

    Molecular techniques for detection of specific Plasmodium nucleic-acid sequence have 65

    enabled measurement of infections that are a log-fold lower than microscopy or antigen detection 66

    tests (18, 20). For example, polymerase chain reaction (PCR) assays allow explicit identification 67

    of malarial species and can be easily adapted for high throughput application. Real-time PCR 68

    (qPCR) especially has improved the application of PCR because the assay is fast, has very low 69

    risk of contamination, is highly sensitive, specific and quantitative. These qualities are not only 70

    on March 25, 2018 by guest

    http://jcm.asm

    .org/D

    ownloaded from

    http://jcm.asm.org/

  • ideal for diagnosis and clinical trials efficacy evaluation, but will increasingly become needed for 71

    use in epidemiological surveys and to evaluate the success of malaria control and elimination 72

    campaigns. Superiority of PCR as a diagnostic tool for detection of Plasmodium over 73

    microscopy has been extensively described. For example in a recent systematic review of 74

    surveys of endemic populations in which P. falciparum prevalence was measured by both 75

    microscopy and PCR-based technique, the prevalence of infection measured by microscopy was 76

    shown to be on average, 50.8% of that measured by PCR (17). 77

    Most PCR assays target DNA of the Plasmodium multicopy 18S ribosomal RNA (rRNA) 78

    genes, which, due to their high copy number and mosaic of conserved and variable regions, 79

    provide an ideal molecular target for malaria genus and species identification and quantification. 80

    However, even slight genetic variation within 18S rRNA gene sequences of the same species has 81

    been problematic. The Plasmodium genome lacks the long tandemly repeated arrays of rRNA 82

    genes found in other eukaryotes. Instead, it contains several, single 18S-5.8S-28S rRNA units 83

    distributed on different chromosomes with sequence encoded by rRNA gene in one unit differing 84

    from the sequence of the corresponding rRNA in the other units (8). Additionally, the expression 85

    of each rRNA unit is developmentally regulated, with different sets of rRNAs being expressed at 86

    different stages of the parasite life cycle (10, 21). As such, it is important to consider all these 87

    factors when designing a nucleic-acid sequence based assay which targets 18S genes. 88

    In this study, we describe development of a highly sensitive genus-specific quantitative 89

    reverse transcriptase real-time PCR (qRT-PCR) assay for detection of Plasmodium and shown 90

    that amplification of total nucleic acids (RNA and DNA) of the 18S rRNA genes significantly 91

    increases analytical sensitivity of the assay. We also compared quantification of clinical samples 92

    in detection of Plasmodium by qRT-PCR and microscopy. 93

    on March 25, 2018 by guest

    http://jcm.asm

    .org/D

    ownloaded from

    http://jcm.asm.org/

  • Material and Methods 94

    Samples. 95

    Samples used in this study were obtained from a Phase IIb pediatric clinical trial conducted 96

    between March 2005 and April 2006 at the KEMRI/Walter Reed Project, Kombewa Clinic in the 97

    Kombewa Division of Kisumu District, Nyanza Province, Western Kenya. The study was 98

    approved by the Ethical Review Committee of the Kenya Medical Research Institute, Nairobi, 99

    Kenya and Walter Reed Army Institute of Research Institute Review Board, Maryland, United 100

    States. 101

    Details about this study have been described elsewhere (23). Briefly, EDTA-treated 102

    blood samples were collected from study participants at enrolment (Day 0) and one month after 103

    administration of the third and final vaccination. In addition, blood was also drawn during 104

    unscheduled clinical visits from children who were sick and suspected to have malaria. For 105

    assessment of malaria, a peripheral blood smear was obtained from subjects who presented to the 106

    Walter Reed Projects Kombewa Clinic with fever or a history of fever within 48 h, or an illness 107

    that the attending doctor suspected might be due to malaria infection. After Giemsa staining, thin 108

    and thick blood smear slides from each sample were independently examined by three expert 109

    microscopists for detection of Plasmodium and count where applicable. All malaria 110

    microscopists were fully trained and were required to pass